280755-12-6

Basic information

• Product Name: Tulathromycin B
• Synonyms: TULATHROMYCIN B;Tulathromycin;(2R,3R,6R,8R,9R,10S,11S,12R)-11-[[2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-a-L-ribo-hexopyranosyl]oxy]-2-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-1-oxa-4-azacyclotridecan-13-one;Tulathromycin B, approximately 5% (As a mixture with Tulathromycin A)
• CAS NO: 280755-12-6
• Molecular Formula: C41H79N3O12
• Molecular Weight: 806.084
• EINECS: 1806241-263-5
• Mol File: 280755-12-6.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 870.5±65.0 °C(Predicted)
• Appearance: /
• Density: 1.17
• Storage Temp.: -20°C Freezer, Under inert atmosphere
• Solubility: DMSO (Slightly), Methanol (Slightly)
• PKA: 13.20±0.70(Predicted)
• CAS DataBase Reference: Tulathromycin B(CAS DataBase Reference)
• NIST Chemistry Reference: Tulathromycin B(280755-12-6)
• EPA Substance Registry System: Tulathromycin B(280755-12-6)

Safety Data

• Hazardous Substances Data: 280755-12-6(Hazardous Substances Data)

Usage

Description

Tulathromycin B is a semi-synthetic macrolide antibiotic derived from the natural macrolide pleuromutilin. It is characterized by its potent antibacterial properties and is widely used in the veterinary industry for the treatment of various bacterial and protozoal infections.

Uses

Used in Veterinary Medicine:
Tulathromycin B is used as an antibiotic for the treatment of bacterial and protozoal infections in animals. Its broad-spectrum activity makes it effective against a wide range of pathogens, including both Gram-positive and Gram-negative bacteria, as well as certain protozoa.
Used in Pharmaceutical Compounds:
Tulathromycin B is also a key component in various veterinary pharmaceutical compounds, where it is combined with other active ingredients to enhance the overall efficacy of the treatment. These compounds are specifically formulated to target different types of infections and are tailored to the needs of different animal species.

Veterinary Drugs and Treatments

In beef and non-lactating dairy cattle, tulathromycin is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni (Haemophilus somnus) and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD, associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni (Haemophilus somnus). In swine, tulathromycin is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, and Haemophilus parasuis.